Presentation
9 March 2020 AI-driven imaging biomarkers for sensory cue integration during melanoma screening (Conference Presentation)
Author Affiliations +
Abstract
Early diagnosis of melanomas is the most effective means of improving melanoma prognosis. We can arm the non-expert screeners with artificial intelligence but most artificial intelligence methods are somewhat impractical in a clinical setting given the lack of transparency. To provide a quantitative and algorithmic approach to lesion diagnosis while maintaining transparency, and to supplement the clinician rather than replace them, our digital analysis provides visual features, or, “imaging biomarkers” that can both be used in machine learning and visualized too.
Conference Presentation
© (2020) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Daniel S. Gareau, Charles Vrattos, James Browning, Samantha R Lish, Benjamin Firester, and James G. Krueger "AI-driven imaging biomarkers for sensory cue integration during melanoma screening (Conference Presentation)", Proc. SPIE 11230, Optics and Biophotonics in Low-Resource Settings VI, 112300U (9 March 2020); https://doi.org/10.1117/12.2550189
Advertisement
Advertisement
KEYWORDS
Melanoma

Image sensors

Optical sensors

Sensors

Artificial intelligence

Diagnostics

Transparency

Back to Top